Trials / Completed
CompletedNCT00092560
Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 587 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the cholesterol lowering effectiveness and safety of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
Detailed description
The duration of treatment is 18 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653, ezetimibe | |
| DRUG | Comparator: fenofibrate monotherapy |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2003-12-01
- Completion
- 2003-12-01
- First posted
- 2004-09-28
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00092560. Inclusion in this directory is not an endorsement.